Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Significant Growth in Short Interest
04:09am, Monday, 13'th Apr 2026
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 216,042 s
Bayer US head says tariffs will not affect its 2026 forecasts
01:38pm, Tuesday, 07'th Apr 2026
A top Bayer AG executive said on Tuesday the German drugmaking and crop science company saw no need to adjust its 2026 forecasts because of tariffs on imported pharmaceuticals announced by the U
Bayer Advances AB-1002 Study, Highlights Pharma Growth Strategy
03:30pm, Thursday, 02'nd Apr 2026
Bayer advances AB-1002 after AskBio completes mid-stage study enrollment, as its Pharma strategy and pipeline milestones drive long-term growth outlook.
Bayer Wins EC Approval to Expand Kerendia in Heart Failure Treatment
02:46pm, Tuesday, 31'st Mar 2026
Bayer wins EU nod to expand Kerendia's use in heart failure, backed by strong phase III data, boosting a key drug driving growth and portfolio momentum.
Following a challenge brought by OLLY PBC, BBB National Programs' National Advertising Division recommended that Bayer HealthCare LLC discontinue or modify certain claims for its One A Day® Men's Pre
BERLIN--(BUSINESS WIRE)--Bayer today announced a leadership change within its Pharmaceuticals' Worldwide Markets organization to accelerate the strong performance and growth of its key pharmaceutical
Bayer: Turnaround Is Underway - Don't Miss It
11:30am, Thursday, 26'th Mar 2026
Bayer remains a 'Buy' as litigation overhangs ease and intrinsic value points to deep undervaluation. Despite disappointing 2025 results, Bayer's core business shows resilience, with litigation settle
Bayer Crop Science Canada Redefines Canola Innovation With New "Advancing Better Canola" Initiative
11:30am, Thursday, 26'th Mar 2026
CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science Canada launches Advancing Better Canola (ABCs), an industry-wide initiative to challenge and redefine how it thinks about canola innovation in sup
Short Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Grows By 178.9%
02:56am, Wednesday, 25'th Mar 2026
Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the target of a significant increase in short interest in March. As of March 13th, there was short interest totaling 123,788 shares, an i
BAYRY Reports Positive Data on Kidney Drug in Non-Diabetic CKD
02:06pm, Tuesday, 17'th Mar 2026
Bayer's finerenone hits key phase III goal in non-diabetic CKD, paving the way to expand Kerendia???s use as data strengthens its cardiorenal therapy role.
Bayer Crop Science Launches 2026 Opportunity Scholarship Program
11:00am, Monday, 16'th Mar 2026
CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science Canada is excited to support the future of Canadian agriculture with its 2026 Bayer Crop Science Opportunity Scholarship. Through the scholarship,
Bayer takes its multi-front battle on pesticide liability to Kansas
04:05pm, Tuesday, 10'th Mar 2026
Kansas lawmakers were set to take up a bill on Tuesday backed by Bayer that would prevent people from suing pesticide manufacturers for not warning them that their products could cause cancer or ot
Bayer Advances Roundup Settlement With Missouri Court Approval
01:45pm, Thursday, 05'th Mar 2026
BAYRY wins preliminary court approval for a proposed Roundup class settlement, a key step in managing long-running glyphosate litigation and future liabilities.
Bayer Aktiengesellschaft (BAYRY) Q4 2025 Earnings Call Transcript
05:12pm, Wednesday, 04'th Mar 2026
Bayer Aktiengesellschaft (BAYRY) Q4 2025 Earnings Call Transcript
Bayer's $7.25 billion Roundup settlement gets initial OK from Missouri judge
01:17pm, Wednesday, 04'th Mar 2026
A state court judge in Missouri gave an initial green light on Wednesday to a proposed $7.25 billion settlement to resolve thousands of lawsuits claiming Bayer's Roundup weedkiller causes cancer
